Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

On 1 October 2019, the University of Oxford and the University of British Columbia (UBC) signed a Memorandum of Understanding, committing to work together to develop a new generation of clinical research leaders who will transform the translation of novel therapies from laboratory to clinic.

None © Photo credit: Kai Jacobson
(Left to right) Dr Dermot Kelleher, Dean of the UBC Faculty of Medicine, and Sir Gordon Duff, Principal of St Hilda’s College Oxford

As part of this initiative, UBC has created the Sultan Karim Fellowships in Clinical Pharmacology, which will support up to four clinicians seeking further research training and education in Clinical Pharmacology. This follows the establishment in 2017 of the Climax Chair of Clinical Therapeutics and Fellowships at St Hilda’s College. The Sultan Karim Fellowships and the Climax Chair and Fellowships have all been created thanks to the vision of Professor John Climax, an early champion of the field of Clinical Pharmacology and Therapeutics.

Read more (St Hilda's College website)

Similar stories

Language learning difficulties in children linked to brain differences

A new study using MRI has revealed structural brain changes in children with developmental language disorder (DLD), a common but under-recognised difficulty in language learning. Children with DLD aged 10-15 showed reduced levels of myelin in areas of the brain associated with speaking and listening to others, and areas involved in learning new skills. This finding is a significant advance in our understanding of DLD and these brain differences may explain the poorer language outcomes in this group.

The Gene Therapists Headline at Glastonbury 2022

Rosie Munday writes about her experience taking science to the masses at the Glastonbury Festival.

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).